ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,055, issued on July 28, was assigned to ELI LILLY AND COMPANY (Indianapolis).
"Incretin analog-containing compositions and uses thereof" was invented by Ganapathy Gopalrathnam (Fishers, Ind.) and Christopher Sears Minie (Zionsville, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A composition is provided that includes an incretin analog having activity at each the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors (i.e., tri-receptor agonist) and one or more additional agents such as a tonicity agent and a preservative. Methods also are provided for treating diseases such as type 2 d...